Thomas Danne

Active 1993–2025

131
Papers
19,665
Citations
67
h-index
127
i10-index

Citations

Citations per year for Thomas Danne1991: 1 citations1993: 1 citations1994: 5 citations1995: 3 citations1996: 6 citations1997: 7 citations1998: 6 citations1999: 11 citations2000: 10 citations2001: 16 citations2002: 13 citations2003: 23 citations2004: 34 citations2005: 37 citations2006: 40 citations2007: 43 citations2008: 55 citations2009: 69 citations2010: 26 citations2011: 40 citations2012: 35 citations2013: 62 citations2014: 106 citations2015: 68 citations2016: 79 citations2017: 74 citations2018: 180 citations2019: 572 citations2020: 763 citations2021: 801 citations2022: 692 citations2023: 677 citations2024: 1,102 citations2025: 553 citations2026: 27 citations1992: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,689 citing papers, 22.3% of this breakdownUnited Kingdom: 681 citing papers, 9% of this breakdownGermany: 435 citing papers, 5.7% of this breakdownItaly: 429 citing papers, 5.7% of this breakdownAustralia: 335 citing papers, 4.4% of this breakdownCanada: 284 citing papers, 3.8% of this breakdownChina: 283 citing papers, 3.7% of this breakdownDenmark: 265 citing papers, 3.5% of this breakdownSpain: 209 citing papers, 2.8% of this breakdownSweden: 204 citing papers, 2.7% of this breakdownFrance: 183 citing papers, 2.4% of this breakdownNetherlands: 176 citing papers, 2.3% of this breakdown
0%22.3%Other 31.7%

Fields

  • Medicine84%
  • Biochemistry, Genetics and Molecular Biology10%
  • Health Professions2.1%
  • Engineering0.9%
  • Computer Science0.7%
  • Psychology0.4%
  • Other1.9%

Topics

  • Diabetes Management and Research24.7%
  • Diabetes and associated disorders12.5%
  • Pancreatic function and diabetes12.4%
  • Diabetes Treatment and Management7.2%
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients6.7%
  • Diabetes Management and Education3.2%
  • Other33.3%

Coauthors

All papers

Open in search
  1. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Helen R. Murphy, Revital Nimri, Kirsten Nørgaard, Christopher G. Parkin, Éric Renard, David Rodbard, Banshi Saboo, Desmond Schatz, Keaton Stoner, Tatsuiko Urakami, Stuart A. Weinzimer, Moshe Phillip - Diabetes Care 2019 cited by 3,797

  2. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julio Rosenstock, Banshi Saboo, Kohjiro Ueki, Guillermo E Umpierrez, Stuart A. Weinzimer, Moshe Phillip - The Lancet Diabetes & Endocrinology 2022 cited by 725

  3. International Consensus on Use of Continuous Glucose Monitoring

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mauro Scharf, William V. Tamborlane, Stuart A. Weinzimer, Moshe Phillip - Diabetes Care 2017 cited by 2,026

  4. Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin de Bock, Daniel J. DeSalvo, J. Hans DeVries, Klemen Dovč, Francis J. Doyle, Laya Ekhlaspour, Naama Fisch Shvalb, Gregory P. Forlenza, Geraldine Gallen, Satish K. Garg, Dana Gershenoff, Linda Gonder‐Frederick, Ahmad Haidar, Sara Hartnell, Lutz Heinemann, Simon Heller, Irl B. Hirsch, Korey K. Hood, Diana Isaacs, David C. Klonoff, Olga Kordonouri, Aaron J. Kowalski, Lori M. Laffel, Julia Lawton, Rayhan Lal, Lalantha Leelarathna, David M. Maahs, Helen Murphy, Kirsten Nørgaard, David N. O’Neal, Sean M. Oser, Tamara K. Oser, Éric Renard, Michael C. Riddell, David Rodbard, Steven J. Russell, Desmond Schatz, Viral N. Shah, Jennifer L. Sherr, Gregg D. Simonson, R. Paul Wadwa, Candice Ward, Stuart A. Weinzimer, Emma G. Wilmot, Tadej Battelino - Endocrine Reviews 2022 cited by 402

  5. A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kelly L. Close, Curtiss B. Cook, Thomas Danne, Francis J. Doyle, Angela Drincic, Kathleen Dungan, Steven V. Edelman, Niels Ejskjær, Juan Espinoza, G. Alexander Fleming, Gregory P. Forlenza, Guido Freckmann, Rodolfo J. Galindo, Ana María Gómez, Hanna A. Gutow, Lutz Heinemann, Irl B. Hirsch, Thanh D. Hoang, Roman Hovorka, Johan Jendle, Linong Ji, Shashank Joshi, Michaël Joubert, Suneil K. Koliwad, Rayhan Lal, M. Cecilia Lansang, Wei-An Lee, Lalantha Leelarathna, Lawrence A. Leiter, Marcus Lind, Michelle L. Litchman, Julia K. Mader, Katherine Mahoney, Boris Mankovsky, Umesh Masharani, Nestoras Mathioudakis, Alexander Yur'evich Mayorov, Jordan Messler, Joshua D. Miller, Viswanathan Mohan, James H. Nichols, Kirsten Nørgaard, David N. O’Neal, Francisco J. Pasquel, Athena Philis‐Tsimikas, Thomas R. Pieber, Moshe Phillip, William H. Polonsky, Rodica Pop‐Busui, Gerry Rayman, Eun‐Jung Rhee, Steven J. Russell, Viral N. Shah, Jennifer L. Sherr, Koji Sode, Elias K. Spanakis, Deborah J. Wake, Kayo Waki, Amisha Wallia, Melissa E. Weinberg, Howard Wolpert, Eugene E. Wright, Mihail Zilbermint, Boris Kovatchev - Journal of Diabetes Science and Technology 2022 cited by 276

  6. A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial

    Authors: , , , , , , , , , , , , , , , , , , , , , - The Lancet 2021 cited by 328

  7. Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lori M. Laffel, Michelle L. Katz, Elvira Isganaitis, Sanjeev N. Mehta, Heidi Quinn, Nisha Naik, Zijing Guo, Lisa K. Volkening, Robert H. Slover, Gregory P. Forlenza, R. Paul Wadwa, G. Todd Alonso, Laurel H. Messer, Lindsey Towers, Katie Thivener, Cari Berget, Samantha Lange, Emily Jost, Maria Rossick-Solis, Desmond Schatz, Michael J. Haller, Paul Hiers, Laura M. Jacobsen, Madison B. Smith, Anastasia O’Neill, Jennifer Hosford, Alexis Perry, Stuart A. Weinzimer, Eda Cengiz, Jennifer L. Sherr, Kathryn Gibbons, Lori Carria, Melinda Zgorski, Thomas Danne, Torben Biester, Olga Kordonouri, Thekla von dem Berge, Sarah Biester, K Remus - Nature Medicine 2020 cited by 237

  8. Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 2017 cited by 416

  9. International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Diabetes Care 2019 cited by 356

  10. Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Minu George, Edgar R. Gonzalez, Michael Gottschalk, Giancarlo Guido, Amir Ali Hassan, Eli Hershkovitz, Lina Huerta‐Saenz, Jin Soon Hwang, Jaime Orlando Ibarra Gomez, Lydia Irizarry Gonzalez, Nina Jain, David H. Jelley, Ho-Seong Kim, T. A. Kovalenko, Lori M. Laffel, Steven B. Leichter, Raphael Del Roio Liberatore, Jane Lynch, Farid H. Mahmud, Oleg Arturovich Malievskiy, Andrew Muir, Bryce Nelson, Luis Alejandro Nevarez Ruiz, Micah L. Olson, Emilia Susana Pelayo Orozco, Valentina Peterkova, Fernando Ramón Ramírez Mendoza, Konda Mohan Reddy, Henry Rodriguez, Javier Andres Saenz, Julia Samoilova, Karl‐Otfried Schwab, S Shah, Naim Shehadeh, Ashley H. Shoemaker, Yulia Skorodok, Aleksandr Sobolev, Silvana Ernestina Solís, Shylaja Srinivasan, William V. Tamborlane, Eva Tsalikian, Ф. В. Валеева, Carl D Vance, Pedro Velasquez‐Mieyer, R. Ortiz, Olga Votyakova, Haiyan Wei, Ruth S. Weinstock, Mark D. Wheeler, Brandy Wicklow, Steven M. Willi, Kupper A. Wintergerst, Risa M. Wolf, Jamie Wood, Chandan Yaliwal, Hernán Yupanqui Lozno - The Lancet Diabetes & Endocrinology 2023 cited by 103

  11. Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study

    Authors: , , , , , , , , , , , , , , - Diabetes Care 2018 cited by 228

  12. Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Heba M. Ismail, Laura M. Jacobsen, Suzanne Bennett Johnson, Leslie E. Kolb, Olga Kordonouri, Karin Lange, Robert W. Lash, Åke Lernmark, Ingrid Libman, Markus Lundgren, David M. Maahs, M. Loredana Marcovecchio, Chantal Mathieu, Kellee M. Miller, Holly K. O’Donnell, Tal Oron, Shivajirao P. Patil, Rodica Pop‐Busui, Marian Rewers, Stephen S. Rich, Desmond Schatz, Rifka Schulman‐Rosenbaum, Kimber M. Simmons, Emily K. Sims, Jay S. Skyler, Laura Smith, Cate Speake, Andrea K. Steck, Nicholas Thomas, Ksenia N. Tonyushkina, Riitta Veijola, John M. Wentworth, Diane K. Wherrett, Jamie Wood, Anette‐Gabriele Ziegler, Linda A. DiMeglio - Diabetes Care 2024 cited by 68

  13. HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study

    Authors: , , , , , , , , , , , - Diabetes Care 2018 cited by 183

  14. New Definition for the Partial Remission Period in Children and Adolescents With Type 1 Diabetes

    Authors: , , , , , , , , , , , - Diabetes Care 2009 cited by 314

  15. The SWEET Project 10-Year Benchmarking in 19 Countries Worldwide Is Associated with Improved HbA1c and Increased Use of Diabetes Technology in Youth with Type 1 Diabetes

    Authors: , , , , , , , , , - Diabetes Technology & Therapeutics 2021 cited by 105

  16. ISPAD Clinical Practice Consensus Guidelines 2022: Insulin treatment in children and adolescents with diabetes

    Authors: , , , , , , , , , , - Pediatric Diabetes 2022 cited by 88

  17. Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Heba M. Ismail, Laura M. Jacobsen, Suzanne Bennett Johnson, Leslie E. Kolb, Olga Kordonouri, Karin Lange, Robert W. Lash, Åke Lernmark, Ingrid Libman, Markus Lundgren, David M. Maahs, M. Loredana Marcovecchio, Chantal Mathieu, Kellee M. Miller, Holly K. O’Donnell, Tal Oron, Shivajirao P. Patil, Rodica Pop‐Busui, Marian Rewers, Stephen S. Rich, Desmond Schatz, Rifka Schulman‐Rosenbaum, Kimber M. Simmons, Emily K. Sims, Jay S. Skyler, Laura Smith, Cate Speake, Andrea K. Steck, Nicholas Thomas, Ksenia N. Tonyushkina, Riitta Veijola, John M. Wentworth, Diane K. Wherrett, Jamie Wood, Anette‐Gabriele Ziegler, Linda A. DiMeglio - Diabetologia 2024 cited by 58

  18. Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol

    Authors: , , , - Diabetes Technology & Therapeutics 2018 cited by 104

  19. Liraglutide in an Adolescent Population with Obesity: A Randomized, Double-Blind, Placebo-Controlled 5-Week Trial to Assess Safety, Tolerability, and Pharmacokinetics of Liraglutide in Adolescents Aged 12-17 Years

    Authors: , , , , , , , - The Journal of Pediatrics 2016 cited by 122

  20. Longitudinal Changes in Continuous Glucose Monitoring Use Among Individuals With Type 1 Diabetes: International Comparison in the German and Austrian DPV and U.S. T1D Exchange Registries

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrea Gerard‐Gonzalez, Melanie Cree‐Green, Susan J. Gross, Shideh Majidi, Laurel H. Messer, Tyler Reznick-Lipina, Emily Simmons, Katie Thivener, Isabel Weber, Steven M. Willi, Terri H. Lipman, Olena Kucheruk, Pantea Minnock, Cathy Carchidi, Brian Grant, Diana R. Olivos, Linda A. DiMeglio, Tamara S. Hannon, Carmella Evans‐Molina, David W. Hansen, Tina M. Pottorff, Stephanie L. Woerner, Megan Hildinger, Robin Hufferd, America Newnum, Devyn Purtlebaugh, Lisa Smith, Kathleen Wendholt, Robin Goland, Rachelle Gandica, Kristen M. Williams, Sarah Pollack, Emily Casciano, Julia Hochberg, Cecilia Uche, Joyce M. Lee, Brigid Gregg, Meng H. Tan, Lynn Ang, Rodica Pop‐Busui, Inas H. Thomas, Emily Dhadphale, Janet Dominowski, Ashley Garrity, Virginia Leone, Cynthia Plunkett, Brittany Plunkett, Roshanak Monzavi, Clement S.K. Cheung, Lynda K. Fisher, Mimi S. Kim, Brian Miyazaki, Pisit Pitukcheewanont, Anna Sandström, Juliana Austin, Nancy Change, Jennifer K. Raymond, Brian Ichihara, Megan Lipton, Jaquelin Flores Garcia, Satish K. Garg, Aaron W. Michels, Rachel Garcetti, Melanie Cree‐Green, Raymond Gutin, Kristen J. Nadeau, Sarit Polsky, Viral N. Shah, Mary Voelmle, L. Daniel Myers and 499 more - Diabetes Care 2019 cited by 94

  21. The Digital/Virtual Diabetes Clinic: The Future Is Now—Recommendations from an International Panel on Diabetes Digital Technologies Introduction

    Authors: , , , , , , , , , , , - Diabetes Technology & Therapeutics 2020 cited by 143

  22. INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , M. Cnop, Søren Brunak, Flemming Pociot, Jesper Johannesen, Peter Rossing, C. Legido Quigley, Roberto Mallone, Raphaël Scharfmann, Christian Boîtard, Mikael Knip, Timo Otonkoski, Riitta Veijola, Riitta Lahesmaa, M. Oresic, Jorma Toppari, Thomas Danne, Anette‐Gabriele Ziegler, Peter Achenbach, T. Rodriguez-Calvo, Michele Solimena, Ezio Bonifacio, Stephan Speier, Reinhard W. Holl, Francesco Dotta, F. Chiarelli, P. Marchetti, Emanuele Bosi, Stefano Cianfarani, Paolo Ciampalini, Carine de Beaufort, Knut Dahl‐Jørgensen, Torild Skrivarhaug, Geir Joner, L. Krogvold, Przemysława Jarosz‐Chobot, Tadej Battelino, B. Thorens, Martin Gotthardt, Bart O. Roep, Tatjana Nikolić, Arnaud Zaldumbide, Åke Lernmark, Markus Lundgren, Guillaum Costecalde, T. Strube, Anke M. Schulte, Almut Nitsche, Matthias von Herrath, Johnna D. Wesley, Antonella Napolitano-Rosen, Marius Thomas, Nanette C. Schloot, A. Goldfine, Frank Waldron-Lynch, J. Kompa, A. Vedala, N. Hartmann, Gwenaelle Nicolas, Jean Van Rampelbergh, N. Bovy, Srijana Dutta, John Soderberg, Simi Ahmed, Frank B. Martin, G. Agiostratidou, A. Koralova, Ruben H. Willemsen, Anne Smith, Bawani Anand, V. Puthi and 40 more - Trials 2022 cited by 39

  23. C ontinuous glucose monitoring‐based time‐in‐range using insulin glargine 300 units/ ml versus insulin degludec 100 units/ ml in type 1 diabetes: The head‐to‐head randomized controlled InRange trial

    Authors: , , , , , , , , , - Diabetes Obesity and Metabolism 2022 cited by 36

  24. Guidelines adherence in the prevention and management of chronic kidney disease in patients with diabetes mellitus on the background of recent European recommendations – a registry-based analysis

    Authors: , , , , , , , , , , - BMC Nephrology 2021 cited by 33